Infertility Diagnosis And Treatment Market
Infertility Diagnosis And Treatment Market By Diagnosis, By Infertility Treatment, - Global Industry Share, Growth, Competitive Analysis And Forecast, 2018-2023 Update Available - Forecast 2024-2030
The Global infertility diagnosis and treatment market is expected to grow at CAGR of 6.3% from 2018 to 2023. In Vitro Fertilization (IVF) is the largest segment of infertility diagnosis and treatment market and expected to be the largest segment in the forecast year, however, Semen Analysis is the fastest growing segment of infertility diagnosis and treatment market during the forecast period of 2018-2023. Lifestyle factors such as smoking, stress, weight and also the female age factor (age above 35 years) are the reason behind infertility. The Global infertility diagnosis and treatment market is broadly categorized into two segments Male and female infertility. Male and female infertility market further divided in two major category Infertility Diagnosis and treatment market.
Geographically, global infertility diagnosis and treatment market is divided into North America, Europe, Asia Pacific and Rest of the world. North America is the largest market for infertility diagnosis and treatment owing to changing lifestyle, increasing the geriatric population, rising awareness regarding infertility diagnosis and treatment are some of the few factors that pushes this region upward. However, APAC is growing at a massive pace owing to increasing medical tourism, and so on. China and India are the major countries in this region.
Key companies profiled in the report are Bayer AG, Bristol-Myers Squibb CO., Church & Dwight Company INC., Cook Medical, INC., Coopersurgical INC., Eli Lilly & CO., Emd Serono, INC., Endo Pharmaceuticals INC., Ferring Pharmaceuticals, Genea, Glaxosmithkline PLC, Halotech DNA, Irvine Scientific, Janssen Pharmaceutical, Novartis International AG, Origio, Ovascience, Pfizer Inc., Princeton Biomeditech CORP., Progyny, Quidel CORP., Vitrolife AB, Vivus INC. These companies use many strategies such as merger and acquisition, product launch, geographical expansion and so on to dominate their global presence.
Research methodology
The market study of infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary sources Include
- Financial reports of companies involved in the market
- Authentic Public Databases
- Whitepapers, research-papers and news blogs
- Company websites and their product catalogue.
- Supplier Websites such as Alibaba, Amazon for pricing analysis.
The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
Market segmentation
Global infertility diagnosis and treatment market is segmented on the basis of infertility diagnosis, infertility treatment and regional outlook.
- Global Infertility diagnosis and treatment Market Research and Analysis, By infertility diagnosis
- Global Infertility diagnosis and treatment Market Research and Analysis, By infertility treatment
- Global infertility diagnosis and treatment Market Research and Analysis, By Region
The report Covers
- Comprehensive research methodology of global infertility diagnosis and treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the infertility diagnosis market.
- Insights about market determinants which are stimulating the global infertility diagnosis and treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. TAX LAWS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
2.3.1.5. REST OF THE WORLD
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. LIFESTYLE FACTOR SUCH AS SMOKING, STRESS AND WEIGHT AUGMENT THE INFERTILITY
3.1.2. FEMALE AGE FACTOR (AGE ABOVE 35 YEARS)
3.1.3. INCREASED SUCCESS RATE OF IVF TREATMENT IS DRIVING THE MARKET
3.1.4. HIGH PREVALENCE RATE OF INFERTILITY IN MALE AND FEMALE BOTH
3.1.5. INCREASE IN NEW TECHNOLOGIES TO AVOID MULTIPLE EMBRYO IMPLANTS
3.2. RESTRAINTS
3.2.1. COST STRUCTURE IS A RESTRAINT FOR THE MARKET
3.2.2. LACK OF INFRASTRUCTURE IN DEVELOPING COUNTRIES
3.2.3. REIMBURSEMENT POLICIES IN VARIOUS GEOGRAPHIES ARE RESTRAINING THE MARKET
3.3. OPPORTUNITIES
3.3.1. EMERGING MARKET SUCH AS INDIA AND CHINA ARE MOST OPPORTUNITY MARKETS
3.3.2. MEDICAL TOURISM IN DEVELOPING COUNTRIES
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY DIAGNOSIS
4.1.1. MALE INFERTILITY DIAGNOSIS
4.1.1.1. SEMEN ANALYSIS
4.1.1.2. GENETIC TESTING
4.1.1.3. TESTICULAR BIOPSY
4.1.1.4. HORMONE TESTING
4.1.1.5. OTHER TESTING
4.1.2. FEMALE INFERTILITY DIAGNOSIS
4.1.2.1. OVULATION TESTING
4.1.2.2. HYSTEROSALPINGOGRAPHY
4.1.2.3. HYSTEROSCOPY
4.1.2.4. IMAGING TESTING
4.1.2.5. OVARIAN RESERVE TESTING
4.1.2.6. HORMONAL LEVEL TESTING
4.1.2.7. GENETIC TESTING
4.1.2.8. OTHERS TESTING
4.2. GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY INFERTILITY TREATMENT
4.2.1. MALE INFERTILITY TREATMENT
4.2.1.1. DRUGS AND MEDICINE
4.2.1.2. SURGICAL
4.2.1.3. ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
4.2.1.4. OTHERS
4.2.2. FEMALE INFERTILITY TREATMENT
4.2.2.1. DRUGS AND MEDICINE
4.2.2.2. SURGICAL
4.2.2.3. INTRAUTERINE INSEMINATION (IUI)
4.2.2.4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
4.2.2.4.1. IN VITRO FERTILIZATION
4.2.2.4.2. INTRACYTOPLASMIC SPERM INJECTION (ICSI)
4.2.2.4.3. ASSISTED HATCHING
4.2.2.5. OTHERS
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1.1. BAYER AG
7.1.2. BRISTOL-MYERS SQUIBB CO.
7.1.3. CHURCH & DWIGHT COMPANY INC.
7.1.4. COOK MEDICAL, INC.
7.1.5. COOPERSURGICAL INC.
7.1.6. ELI LILLY & CO.
7.1.7. EMD SERONO, INC
7.1.8. ENDO PHARMACEUTICALS INC.
7.1.9. FERRING PHARMACEUTICALS
7.1.10. GENEA
7.1.11. GLAXOSMITHKLINE PLC
7.1.12. HALOTECH DNA
7.1.13. IRVINE SCIENTIFIC
7.1.14. JANSSEN PHARMACEUTICAL
7.1.15. NOVARTIS INTERNATIONAL AG
7.1.16. ORIGIO
7.1.17. OVASCIENCE
7.1.18. PFIZER INC.
7.1.19. PRINCETON BIOMEDITECH CORP.
7.1.20. PROGYNY
7.1.21. QUIDEL CORP
7.1.22. VITROLIFE AB
7.1.23. VIVUS INC.
TABLE # 1 GLOBAL MARKET RESEARCH AND ANALYSIS BY, INFERTILITY DIAGNOSIS AND TREATMENT EQUIPMENT 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY DIAGNOSIS 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL HORMONE TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL OTHER TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL OVULATION TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL IMAGING TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL OTHERS TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY TREATMENT 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 20 GLOBAL DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 21 GLOBAL SURGICAL MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 22 GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 23 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 24 GLOBAL FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 25 GLOBAL DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 26 GLOBAL SURGICAL MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 27 GLOBAL INTRAUTERINE INSEMINATION (IUI) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 28 GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 29 GLOBAL IN VITRO FERTILIZATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 30 GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 31 GLOBAL ASSISTED HATCHING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 32 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 33 STRATEGY OF LEADING PLAYER
TABLE # 34 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 35 NORTH AMERICA INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY DIAGNOSIS 2017-2023 ($MILLION)
TABLE # 36 NORTH AMERICA INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY TREATMENT 2017-2023 ($MILLION)
TABLE # 37 NORTH AMERICA INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
TABLE # 38 EUROPE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY DIAGNOSIS 2017-2023 ($MILLION)
TABLE # 39 EUROPE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY TREATMENT 2017-2023 ($MILLION)
TABLE # 40 EUROPE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
TABLE # 41 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY DIAGNOSIS 2017-2023 ($MILLION)
TABLE # 42 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY TREATMENT 2017-2023 ($MILLION)
TABLE # 43 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
TABLE # 44 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY DIAGNOSIS 2017-2023 ($MILLION)
TABLE # 45 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY INFERTILITY TREATMENT 2017-2023 ($MILLION)
TABLE # 46 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
FIGURE # 1 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY INFERTILITY DIAGNOSIS, 2017 AND 2023, (IN %)
FIGURE # 2 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY INFERTILITY TREATMENT, 2017 AND 2023, (IN %)
FIGURE # 3 GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, BY GEOGRAPHY, 2017 AND 2023, (IN %)
FIGURE # 4 NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 UNITED STATES INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 UK INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 FRANCE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ITALY INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ROE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 INDIA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 CHINA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 JAPAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 ROPAC INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
